Current Management of NAFLD
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in Western countries. It affects about 1 billion individuals worldwide. While people with simple steatosis have no higher risk of death than the general population, people with non-alcoholic steatohepatitis a...
Main Authors: | MUNTEANU, MIHAI ALEXANDRU, NAGY, GEORGIANA ANCA, MIRCEA, PETRU ADRIAN |
---|---|
Format: | Online |
Language: | English |
Published: |
Iuliu Hatieganu University of Medicine and Pharmacy
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777464/ |
Similar Items
-
From NAFLD to Cardiovascular Disease. Is it (Still) the Metabolic Syndrome?
by: MUNTEANU, MIHAI ALEXANDRU, et al.
Published: (2014) -
The Role of Metformin in the Management of NAFLD
by: Mazza, Angela, et al.
Published: (2012) -
NAFLD and Chronic Kidney Disease
by: Marcuccilli, Morgan, et al.
Published: (2016) -
Practice Guidelines on NAFLD
by: Palmer, Melissa
Published: (2013) -
Noninvasive Methods to Diagnose NAFLD
by: Sureka, Binit, et al.
Published: (2015)